| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.39 | 0.2 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.27 | 0.4 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.26 | 0.2 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.24 | 0.4 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.24 | 1e-06 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.23 | 4e-06 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.22 | 0.06 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.2 | 2e-09 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.2 | 2e-05 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.2 | 0.3 |